By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Recognizing that traditional informed consent policies for medical research are not likely to be adequate for genomic biobanks, a group of legal and bioethics researchers at Duke University and the University of North Carolina have proposed that a trade-secret model could be employed as an alternative.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.